Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Clinical trial update reporting safety and exploratory efficacy results for NEUROSTEM in Alzheimer's disease across Phase 1 and Phase 2, com…
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating flortaucipir PET signal and cognitive change in early Alzheimer’s disease has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's [Phase 4]
Phase 4 trial update evaluating antihypertensives in individuals at risk for Alzheimer's disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects [Phase 2, Phase 3]
Phase 2/3 clinical trial update for 18F-AV-1451 PET imaging in cognitively healthy, mild cognitive impairment, and Alzheimer's disease subje…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 [Phase 2]
Phase 2 clinical trial update for 18F-AV-1451 in Alzheimer's disease, reporting follow-up scan results from confirmatory cohort (Study 18F-A…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Tau Screening Study in Subjects With Early Symptomatic AD [Phase 2]
Phase 2 clinical trial update for tau screening in early symptomatic Alzheimer's disease completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Tau Screening Study in Patients With Early Symptomatic AD [Phase 2]
Phase 2 clinical trial update for tau screening in early symptomatic Alzheimer Disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation [Phase 3]
A Phase 3 reader study evaluating the accuracy and reliability of Flortaucipir F-18 PET scan interpretation for Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Augmenting Flortaucipir Dosimetry Estimates [Phase 1]
Phase 1 clinical trial update focusing on dosimetry estimates for flortaucipir in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for ladostigil in mild to moderate probable Alzheimer's disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Alzheimer's Prevention Through Exercise [NA]
A completed clinical trial exploring whether exercise prevents or impacts Alzheimer's disease progression.
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Seizure Activity in Alzheimer's Disease [NA]
Completed clinical trial investigating seizure activity in Alzheimer's disease; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Randomized Controlled Trial to Test an Alzheimer's Family Caregiver Intervention in Vietnam [NA]
A completed randomized controlled trial evaluated an Alzheimer's disease family caregiver intervention conducted in Vietnam; results have be…
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) [Phase 3]
Phase 3 study of crenezumab versus placebo in prodromal to mild Alzheimer's disease was terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). [Phase 3]
Phase 3 trial evaluating crenezumab in prodromal to mild Alzheimer's disease was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly [Phase 4]
Phase 4 trial update evaluating olfactory deficits and donepezil treatment in cognitively impaired elderly; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients [Phase 2]
Phase 2 trial evaluating GV1001 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial evaluating the safety, tolerability, and efficacy of Lecozotan SR in outpatients with Alzheimer's disease has completed phase…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial update evaluating flexible dosing of brexpiprazole for agitation in Alzheimer's disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 [Phase 2]
Phase 2 double-blind, placebo-controlled safety and efficacy study of NA-831 in cognitive impairment disorders has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Safety and Efficacy of Nabilone in Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update on nabilone for Alzheimer's disease evaluating safety and efficacy across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: Pragmatic Trial of Video Education in Nursing Homes [NA]
A pragmatic trial evaluating video education in nursing homes has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation [Phase 3]
Phase 3 trial evaluating two fixed doses of brexpiprazole for agitation in Alzheimer's disease; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: An Open-Label Crenezumab Study in Participants With Alzheimer's Disease [Phase 3]
An open-label Phase 3 trial of crenezumab in participants with Alzheimer's disease was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia [Phase 2]
Phase II study of CPC-201 for Alzheimer's disease has completed; results posted in 2020.